ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3,3,Sputum abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
3,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
7,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
7,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
9,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
10,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
12,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
13,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
14,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
14,2,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
14,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
15,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
15,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
16,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
16,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
17,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
17,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
17,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
17,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
18,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
19,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
19,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
20,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
21,1,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
22,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
22,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
22,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
23,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
24,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
25,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
27,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
27,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
28,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
28,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
28,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
29,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
30,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
31,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
31,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
33,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
34,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
34,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
35,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
36,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
37,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
38,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
38,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
39,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
39,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
40,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
41,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
42,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
43,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
43,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
43,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
44,1,Blood alcohol increased,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
45,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
45,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
46,1,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
47,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
48,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
49,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
49,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
49,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
50,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
50,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
51,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
51,2,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
52,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
52,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
53,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
53,2,Headache,Headaches NEC,Headaches,Nerv,N
53,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
53,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
53,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
53,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
53,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
53,9,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
54,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
54,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
54,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
55,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
57,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
57,2,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
58,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
58,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
60,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
60,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
61,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
61,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
62,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
64,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
65,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
65,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
66,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
67,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
69,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
69,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
69,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
70,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
70,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
71,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
72,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
73,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
73,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
73,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
73,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
74,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
75,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
77,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
78,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
79,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
80,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
80,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
80,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
80,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
81,1,Sleep talking,Parasomnias,Sleep disorders and disturbances,Psych,N
82,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
82,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
83,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
84,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
84,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
86,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
87,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
87,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
87,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
87,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
87,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
88,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
89,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
90,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
91,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
91,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
92,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
92,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
93,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
94,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
94,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
95,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
96,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
96,2,Derealisation,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
97,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
98,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
99,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
99,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
100,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
100,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
101,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
101,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
103,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
104,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
104,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
106,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
106,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
107,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
108,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
108,2,Palatal disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
109,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
109,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
109,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
109,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
110,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
111,1,Headache,Headaches NEC,Headaches,Nerv,N
111,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
112,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
113,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
113,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
114,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
115,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
115,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
116,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
117,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
119,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
120,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
120,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
122,1,Accidental poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
123,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
123,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
123,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
123,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
123,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
124,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
124,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
125,1,5'nucleotidase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
125,3,Anisochromia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
125,4,Anisocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
125,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
125,6,Bromosulphthalein test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
125,8,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,9,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
125,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
125,11,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
125,12,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
125,13,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
125,14,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
125,15,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
125,16,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
125,17,Liver palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
125,18,Liver scan abnormal,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
125,19,Neutrophil toxic granulation present,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
125,20,Occult blood positive,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
125,21,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
125,22,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
126,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
126,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
126,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
126,4,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
126,5,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
126,6,Headache,Headaches NEC,Headaches,Nerv,N
126,7,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
126,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
126,9,Marital problem,Family and partner issues,Family issues,SocCi,N
126,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
126,11,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
126,12,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
126,13,Paranoid personality disorder,Personality disorders with eccentric behaviour (Cluster A),Personality disorders and disturbances in behaviour,Psych,N
126,14,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
126,15,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
126,16,Suspiciousness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
127,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
128,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
128,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
128,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
128,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
128,5,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
129,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
129,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
129,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
129,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
130,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
130,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
131,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
132,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
133,1,Chemical burn of oral cavity,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
133,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
133,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
133,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
133,5,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
133,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
133,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
133,8,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
134,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
134,2,Bronchial disorder,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
134,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
134,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
134,7,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
134,8,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
134,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
134,10,Nocturnal dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
134,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
134,12,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
134,13,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,14,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,15,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,16,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,17,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
134,18,Respiratory tract inflammation,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
134,19,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
135,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
135,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
136,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
137,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
138,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
138,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
139,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
140,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
140,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
141,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
142,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
143,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
143,2,Exposure via direct contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
143,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
143,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
143,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
143,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
144,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
144,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
145,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
146,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
146,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
147,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
148,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
149,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
150,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
150,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
150,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
150,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
151,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
151,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
151,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
152,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
153,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
153,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
154,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
155,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
155,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
155,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
156,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
156,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
157,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
157,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
157,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
157,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
158,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
159,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
160,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
160,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
161,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
162,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
162,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
162,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
163,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
164,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
164,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
165,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
165,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
165,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
165,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
165,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
166,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
166,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
166,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
167,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
167,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
167,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
167,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
167,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
168,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
168,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
168,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
168,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
169,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
169,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
169,3,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
169,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
169,5,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
169,6,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
169,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
169,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
169,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
169,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
171,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
171,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
171,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
171,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
171,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
171,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
172,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
172,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
172,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
174,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
174,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
174,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
175,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
176,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
176,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
177,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,3,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
177,4,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
177,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
177,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
178,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
178,2,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
178,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
179,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
179,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
180,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
180,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
181,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
182,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
182,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
182,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
182,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
182,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
182,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
183,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
184,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
184,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
184,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
185,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
185,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
186,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
186,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
186,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
187,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
187,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
187,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
188,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
188,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
189,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
190,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
190,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
191,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
192,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
192,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
192,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
193,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
193,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
193,3,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
193,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
194,1,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
194,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
195,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
196,1,Migraine,Migraine headaches,Headaches,Nerv,N
196,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
196,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
197,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
198,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
199,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
199,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
200,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
201,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
201,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
201,3,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
201,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
202,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
202,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
203,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
204,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
205,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
205,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
205,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
206,1,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
206,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
206,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
207,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
208,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
208,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
208,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
208,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
209,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
210,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
211,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
211,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
211,3,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
212,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
212,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
212,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
212,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
212,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
212,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
212,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
212,8,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
212,9,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
213,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
213,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
213,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
214,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
215,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
215,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
215,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
216,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
217,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
217,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
217,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
217,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
218,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
218,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
218,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
219,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
219,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
219,3,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
219,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
219,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
219,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
219,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
219,8,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
220,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
220,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
221,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
222,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
222,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
222,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
222,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
223,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
223,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
224,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
224,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
226,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
227,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
228,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
228,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
229,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
229,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
229,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
229,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
229,6,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
229,7,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
229,8,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
229,9,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
229,10,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
229,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
230,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
230,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
230,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
231,1,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
231,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
231,3,Headache,Headaches NEC,Headaches,Nerv,N
231,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
231,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
232,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
232,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
233,1,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
233,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
234,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
234,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
235,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
235,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
236,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
237,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
238,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
238,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
238,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
239,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
239,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
240,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
240,2,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
240,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
240,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
240,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
240,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
241,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
241,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
242,3,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
243,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
243,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
243,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
243,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
243,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
243,6,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
243,7,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
243,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
243,9,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
244,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
245,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
246,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
247,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
247,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
248,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
249,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
249,2,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
249,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
249,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
249,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
249,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
249,7,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
250,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
251,1,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
252,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
252,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
253,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
254,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
254,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
254,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
255,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
256,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
256,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
257,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
257,3,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
257,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
257,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
257,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
257,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
258,1,Hyposmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
258,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
258,3,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
258,4,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
259,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
259,2,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
260,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
260,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
260,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
260,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
260,5,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
261,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
262,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
262,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
263,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
263,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
263,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
263,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
263,5,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
263,6,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
263,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
263,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
263,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
264,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
264,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
264,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
264,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
264,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
264,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
265,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
266,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
266,2,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
266,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
266,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
266,5,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
266,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
267,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
268,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
268,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
269,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
269,2,Dyschezia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
269,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
269,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
269,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
269,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
270,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
270,2,Intentional product misuse to child,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
271,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
271,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
271,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
272,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
272,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
273,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
274,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
276,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
276,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
277,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
277,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
277,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
278,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
279,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
279,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
280,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
281,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
281,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
282,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
283,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
283,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
284,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
285,1,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
285,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
286,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
286,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
287,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
287,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
288,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
289,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
290,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
291,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
291,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
291,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
292,1,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
292,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
293,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
293,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
294,1,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
295,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
295,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
295,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
296,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
296,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
297,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
297,3,Exposure via eye contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
297,4,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
297,5,Eye abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
297,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
297,7,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
297,8,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
297,9,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
297,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
298,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
299,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
300,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
301,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
301,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
302,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
302,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
302,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
302,4,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
302,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
302,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
303,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
303,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
303,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
303,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
304,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
304,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
304,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
305,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
305,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
305,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
306,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
307,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
307,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
307,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
308,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
309,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
310,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
310,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
311,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
311,2,Suspected product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
312,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
312,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
312,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
312,4,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
312,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
313,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
313,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
314,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
314,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
315,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
315,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
315,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
315,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
315,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
316,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
317,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
317,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
317,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
317,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
318,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
318,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
318,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
318,4,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
319,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
319,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
320,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
320,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
320,3,Intentional product misuse to child,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
321,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
322,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
322,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
323,1,Administration site coldness,Administration site reactions NEC,Administration site reactions,Genrl,N
323,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
324,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
324,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
325,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
326,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
326,2,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
327,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
328,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
328,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
328,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
328,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
328,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
329,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
329,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
330,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
330,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
330,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
330,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
330,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
331,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
331,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
331,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
332,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
332,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
332,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
332,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
333,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
333,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
333,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
333,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
334,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
334,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
334,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
335,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
336,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
337,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
338,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
338,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
338,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
338,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
338,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
339,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
339,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
340,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
341,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
341,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
341,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
342,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
342,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
343,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
344,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
344,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
344,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
345,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
345,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
345,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
346,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
346,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
346,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
346,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
347,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
347,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
348,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
349,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
350,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
352,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
352,2,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
352,3,Nasal mucosal blistering,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
353,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
354,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
355,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
355,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
355,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
356,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
356,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
356,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
356,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
357,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
357,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
357,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
357,4,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
357,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
357,6,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
358,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
359,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
360,1,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
361,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
362,1,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
362,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
362,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
363,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
364,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
364,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
365,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
365,2,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
365,3,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
365,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
366,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
366,2,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
366,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
366,4,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
366,5,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
366,6,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
366,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
366,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
